| GUARDANT HEALTH CL. A |
| USA |
| Gesundheit |
| US40131M1099 / A2N5RY |
| 5GH (Frankfurt) / GH (NASDAQ) |
| FRA:5GH, ETR:5GH, 5GH:GR, NASDAQ:GH |
| - |
| https://www.guardanthealt.. |
|
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include t..
>Volltext.. |
| 17861.15 Mio. EUR |
| 18382.4 Mio. EUR |
| 946.43 Mio. EUR |
| -357.59 Mio. EUR |
| -379.54 Mio. EUR |
| -2.98 EUR |
| 1493.45 Mio. EUR |
| 866.77 Mio. EUR |
| -153.9 Mio. EUR |
| 3.77 |
| 30.68% |
| 2.62% |
| - |
| - |
| - |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 49.401.826 Euro. |
| GUARDANT HEALTH |
| 01.07.26 |